Squarepoint
NXTC icon

Squarepoint’s NextCure NXTC Stock Holding History

Squarepoint’s Portfolio NXTC Stock Details NXTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,689
Closed -$98K – 3225
2022
Q1 		$98K Sell
1,689
-440
-21% -$27.5K ﹤0.01% 2604
2021
Q4 		$153K Sell
2,129
-552
-21% -$46.2K ﹤0.01% 2808
2021
Q3 		$217K Sell
2,681
-1,183
-31% -$104K ﹤0.01% 2441
2021
Q2 		$372K Buy
3,864
+2,448
+173% +$250K ﹤0.01% 2369
2021
Q1 		$170K Sell
1,416
-665
-32% -$96.3K ﹤0.01% 2761
2020
Q4 		$272K Buy
+2,081
New +$269K ﹤0.01% 2278
2020
Q2 		– Sell
-1,101
Closed -$490K – 2429
2020
Q1 		$490K Sell
1,101
-93
-8% -$49.7K 0.01% 1056
2019
Q4 		$807K Sell
1,194
-839
-41% -$421K ﹤0.01% 1469
2019
Q3 		$753K Buy
+2,033
New +$661K 0.01% 1407

Other funds holding NXTC

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KPF
K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Squarepoint's NXTC Position: Q2 2022 in Review

Squarepoint sold out of NextCure (NXTC) in Q2 2022, closing a stake of 1,689 shares — an estimated $98K sold.

Squarepoint first reported a position in NXTC in Q3 2019 and held it in 9 quarters. The position peaked at $807K in Q4 2019. 51 funds tracked by Wall St. Rank hold NXTC as of Q2 2022.

  • Squarepoint reported no remaining NextCure position as of Q2 2022 after selling out during the quarter.
  • Squarepoint sold 1,689 NextCure shares in Q2 2022, an estimated $98K.
  • Squarepoint first reported a position in NextCure in Q3 2019 and held it in 9 quarters.
  • Squarepoint's NextCure position peaked at $807K in Q4 2019.
  • 51 funds tracked by Wall St. Rank held NextCure as of Q2 2022.

Based on Squarepoint's 13F filing for Q2 2022, filed 15 Aug 2022.